Reproductive Endocrinology Thyroid and Metabolic Function
RRM Academy Synopsis
Metabolic syndrome in 78 of 122 women with obesity, 24 with PCOS
In this clinic study, 78 of 122 women with obesity had metabolic syndrome, and 24 of those 78 also had PCOS. The study looked at 122 women aged 18 to 40 with regular cycles, seen by family medicine and general practice doctors. PCOS is now also called polyendocrine metabolic ovarian syndrome (PMOS).
Key Findings
- Of 122 women with obesity, 78 had metabolic syndrome and 44 had obesity without metabolic syndrome.
- Among the 78 women with metabolic syndrome, 24 (30.76%) also had PCOS. Six of the 44 women without metabolic syndrome (13.63%) had PCOS.
- Among the 24 women with PCOS and metabolic syndrome, 75% (n=18) had three metabolic syndrome components and 25% (n=6) had four.
- Of the women with PCOS and metabolic syndrome, 70.83% had low HDL cholesterol and 54.17% had high triglycerides.
- Insulin resistance appeared in 50% of women with PCOS and metabolic syndrome and in 46.15% of women with metabolic syndrome.
Interpretation
This cohort study followed 122 women aged 18 to 40 with obesity and regular cycles, seen in family medicine and general practice clinics. PCOS was linked with a much higher rate of metabolic syndrome. Among women with both conditions, low HDL cholesterol, high triglycerides and insulin resistance were common. The authors note that the link between insulin resistance and PCOS is still unclear. They call for screening guidelines to catch metabolic syndrome early in women with PCOS. The findings support larger studies of metabolic screening in PCOS.
RRM Context
Restorative reproductive medicine looks for the underlying cause of ovulation problems, and metabolic health belongs in that search. The 2026 renaming of PCOS to PMOS puts the metabolic side in the name. A cycle chart records ovulation, which clinicians can read alongside the insulin resistance, blood fat and blood pressure markers this paper reports.
Abstract
Women with polycystic ovary syndrome (PCOS) have a high prevalence of metabolic syndrome (MS), with rates up to 33%. This is associated with long-term consequences such as cardiovascular diseases, type 2 diabetes mellitus (T2DM), cancer, sleep apnea, and psychological issues. The prevalence of MS worldwide is often associated with obesity and T2DM, yet regional variations are reported. In this study, 122 women consulting general practice and family medicine physicians were evaluated, revealing a BMI exceeding 30 kg/m2. Among MS criteria, the most common diagnoses were T2DM in 29 patients, insulin resistance (IR) in 36, arterial hypertension (AH) in 51, reduced HDL levels in 53, and elevated triglycerides in 39. Further analysis revealed 16 unique combinations of MS components in these patients, with 75% of PCOS cases exhibiting three MS components and 25% having four. Additionally, research indicated that most women with PCOS face persistent, treatment-resistant obesity, with a notably higher BMI (ρ=0.87; r=0.76). These findings highlight the multifactorial nature of PCOS and MS etiology.
Read the guide
-
PMOS / PCOS: Causes, Diagnosis, and Treatment
PMOS / PCOS has four diagnostic phenotypes and distinct metabolic, reproductive, and mental health implications. How RRM-trained clinicians approach diagnosis and treatment differently.


